Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:SACE_5599, a putative regulatory protein, is involved in morphological differentiation and erythromycin production in Saccharopolyspora erythraea
Avtorji:ID Kirm, Benjamin (Avtor)
ID Magdevska, Vasilka (Avtor)
ID Tome, Miha (Avtor)
ID Horvat, Marinka (Avtor)
ID Karničar, Katarina (Avtor)
ID Petek, Marko (Avtor)
ID Vidmar, Robert (Avtor)
ID Baebler, Špela (Avtor)
ID Jamnik, Polona (Avtor)
ID Fujs, Štefan (Avtor)
ID Horvat, Jaka (Avtor)
ID Fonović, Marko (Avtor)
ID Turk, Boris (Avtor)
ID Gruden, Kristina (Avtor)
ID Petković, Hrvoje (Avtor)
ID Kosec, Gregor (Avtor)
Datoteke:URL URL - Izvorni URL, za dostop obiščite http://www.microbialcellfactories.com/content/12/1/126/abstract
 
.pdf PDF - Predstavitvena datoteka, prenos (1,18 MB)
MD5: 6FCF5943C41D651C3D4D67C8A5BF15ED
 
URL URL - Izvorni URL, za dostop obiščite http://dx.doi.org/10.1186/1475-2859-12-126
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo NIB - Nacionalni inštitut za biologijo
Povzetek:Background Erythromycin is a medically important antibiotic, biosynthesized by the actinomycete Saccharopolyspora erythraea. Genes encoding erythromycin biosynthesis are organized in a gene cluster, spanning over 60 kbp of DNA. Most often, gene clusters encoding biosynthesis of secondary metabolites contain regulatory genes. In contrast, the erythromycin gene cluster does not contain regulatory genes and regulation of its biosynthesis has therefore remained poorly understood, which has for a long time limited genetic engineering approaches for erythromycin yield improvement. Results We used a comparative proteomic approach to screen for potential regulatory proteins involved in erythromycin biosynthesis. We have identified a putative regulatory protein SACE_5599 which shows significantly higher levels of expression in an erythromycin high-producing strain, compared to the wild type S. erythraea strain. SACE_5599 is a member of an uncharacterized family of putative regulatory genes, located in several actinomycete biosynthetic gene clusters. Importantly, increased expression of SACE_5599 was observed in the complex fermentation medium and at controlled bioprocess conditions, simulating a high-yield industrial fermentation process in the bioreactor. Inactivation of SACE_5599 in the high-producing strain significantly reduced erythromycin yield, in addition to drastically decreasing sporulation intensity of the SACE_5599-inactivated strains when cultivated on ABSM4 agar medium. In contrast, constitutive overexpression of SACE_5599 in the wild type NRRL23338 strain resulted in an increase of erythromycin yield by 32%. Similar yield increase was also observed when we overexpressed the bldD gene, a previously identified regulator of erythromycin biosynthesis, thereby for the first time revealing its potential for improving erythromycin biosynthesis. Conclusions SACE_5599 is the second putative regulatory gene to be identified in S. erythraea which has positive influence on erythromycin yield. Like bldD, SACE_5599 is involved in morphological development of S. erythraea, suggesting a very close relationship between secondary metabolite biosynthesis and morphological differentiation in this organism. While the mode of action of SACE_5599 remains to be elucidated, the manipulation of this gene clearly shows potential for improvement of erythromycin production in S. erythraea in industrial setting. We have also demonstrated the applicability of the comparative proteomics approach for identifying new regulatory elements involved in biosynthesis of secondary metabolites in industrial conditions.
Ključne besede:erythromycin, polyketide, regulator, SACE_5599, lmbU, differentiation (biology), sporulation, strain improvement, metabolic engineering
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Datum objave:17.12.2013
Leto izida:2013
Št. strani:str. 126-1-126-15
Številčenje:Vol. 12
PID:20.500.12556/DiRROS-20023 Novo okno
UDK:604.4:615.322:579.873:577.2
ISSN pri članku:1475-2859
DOI:10.1186/1475-2859-12-126 Novo okno
COBISS.SI-ID:3005775 Novo okno
Opomba:El. članek; Nasl. z nasl. zaslona; Opis vira z dne 24. 12. 2013; Članek v formatu PDF obsega 15 str.; Soavtorji: Vasilka Magdevska, Miha Tome, Marinka Horvat, Katarina Karničar, Marko Petek, Robert Vidmar, Špela Baebler, Polona Jamnik, Štefan Fujs, Jaka Horvat, Marko Fonovič, Boris Turk, Kristina Gruden, Hrvoje Petković, Gregor Kosec;
Datum objave v DiRROS:02.08.2024
Število ogledov:2
Število prenosov:4
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Microbial cell factories
Skrajšan naslov:Microb Cell Fact
Založnik:BioMed Central
ISSN:1475-2859
COBISS.SI-ID:2609172 Novo okno

Gradivo je financirano iz projekta

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J4-2195-2009
Naslov:Preučevanje biosinteze eritromicina s proteomskimi orodji

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:J4-4149-2011
Naslov:Preučevanje hom(e)olognih rekombinacij v evoluciji poliketidnih sintaz

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:L4-7117-2005
Naslov:Razvoj in optimizacija bioprocesa industrijskih heterolognih encimov

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0140-2009
Naslov:Proteoliza in njena regulacija

Licence

Licenca:CC BY 2.0, Creative Commons Priznanje avtorstva 2.0 Generična
Povezava:https://creativecommons.org/licenses/by/2.0/deed.sl
Opis:Dovoljuje kopiranje in razširjanje vsebin v kakršnemkoli mediju in obliki. Dovoljuje remixanje, urejanje, predelava in vključevanje vsebine v lastna dela v vse namene, tudi komercialne. Primerno morate navesti avtorja, povezavo do licence in označiti spremembe, če so kakšne nastale. To lahko storite na kakršenkoli razumen način, vendar ne na način, ki bi namigoval na to, da dajalec licence podpira vas ali vašo uporabo dela. Ne smete uporabiti pravnih določil ali tehničnih ukrepov, ki bi pravno omejili ali onemogočilo druge, da bi storili karkoli, kar licenca dovoli.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:aktinomicete, sekundarni metaboliti, eritromicin, regulacija biosinteze, molekularna genetika, Saccharopolyspora erythraea


Nazaj